Clinical trial
China Diabetes Registry - a Prospective Cohort Study of Patients With Diabetes in National Metabolic Management Centers in China
NCT03811470 is registered in ClinicalTrials.gov with Guang Ning as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- China Diabetes Registry - a Prospective Cohort Study of Patients With Diabetes in National Metabolic Management Centers in China
- Lead sponsor
- Guang Ning
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 31, 2017
- Completion date
- May 31, 2039
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
drug-induced diabetes mellitus, monogenetic diabetes, other forms of diabetes mellitus, pancreatogenic diabetes, type 2 diabetes mellitus, type1 diabetes mellitus